Akur8, the machine learning-powered insurance pricing and reserving platform, announced today that it has secured $120 million in series C funding, bringing its total raised investment to $180 million.
Wealth.com has successfully closed a $30 million Series A funding round, led by GV (Google Ventures). This milestone marks a pivotal moment in our journey to modernize and simplify estate planning, an industry that has long been burdened by outdated processes and complexity.
Second Front Systems (2F), a public-benefit software company focused on enabling the delivery of mission-critical software solutions, today announced the close of its $70 million Series C funding round. The round was led by Salesforce Ventures, with participation from new investors, Battery Ventures, and existing investors, NEA, Moore Strategic Ventures, and Artis Ventures.
Strider Technologies, the leading provider of strategic intelligence, has closed $55 million in Series C funding. With this funding, Strider will continue advancing its AI-driven capabilities into its integrated global intelligence platform, expand operations to new geographies in Europe and Asia, and more aggressively address the public sector market.
Inflammatix, a pioneering molecular diagnostics company, announced today the closing of $57 million in Series E financing, led by Khosla Ventures and Think.Health. The funds will support regulatory filing and early commercialization of the company’s lead product, the TriVerity™ Acute Infection and Sepsis Test (TriVerity).
PathPresenter, the global image sharing platform for pathology, announced today that it has closed a Series A funding round of $7.5 million to accelerate the adoption of the company’s enterprise pathology workflow solution.
AceUp, the AI-powered Team Transformation Engine®, announced a $22.5M Series A. The round was led by PJC, Techstars Ventures, Gaingels Ventures, Water Bear Ventures and Launchpad Venture Group.
Syantra, a privately held precision biotechnology company pioneering a platform to change the way cancer is detected and treated, announced that it has raised an additional $4.9 million Canadian Dollars in Series A-1 funding.
Radiant Biotherapeutics, a preclinical biotechnology company developing an antibody platform to deliver transformative therapies for patients facing life-changing disease, announced it has closed a $35 million Series A financing. The round is co-led by the Bill & Melinda Gates Foundation and Amplitude Ventures of Canada.
Smartcat, the enterprise language AI platform, has made waves in the business and tech world after securing $43 million in Series C funding. This funding round, led by Left Lane Capital, will help drive Smartcat’s rapid expansion and solidify its position as a leader in AI multilingual content generation and translation solutions. The extensive media coverage underscores the significance of this funding, highlighting Smartcat's growing influence in the enterprise AI market.
